Non-ST-elevation myocardial infarction with the use of oxymetazoline nasal spray
Oxymetazoline is an alpha-1 adrenergic receptor agonist that is commonly used for nasal decongestion and is readily available without a prescription. We report the case of a 64-year-old woman who developed prolonged chest pain associated with elevation of cardiac biomarkers after using oxymetazoline...
Main Authors: | Saurabh Rajpal, Liam A. Morris, Nuri I. Akkus |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-01-01
|
Series: | Revista Portuguesa de Cardiologia |
Online Access: | http://www.sciencedirect.com/science/article/pii/S087025511300303X |
Similar Items
-
A randomized controlled trial on the effects of oxymetazoline nasal spray after dacryocystorhinostomy among adult patients
by: George Michael N. Sosuan, et al.
Published: (2020-05-01) -
Differential gene expression patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction
by: Mohammad Elahimanesh, et al.
Published: (2024-02-01) -
Efficacy and Safety of Fluticasone Furoate and Oxymetazoline Nasal Spray: A Novel First Fixed Dose Combination for the Management of Allergic Rhinitis with Nasal Congestion
by: Kumar RS, et al.
Published: (2022-06-01) -
Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)
by: Elin Chorell, et al.
Published: (2020-12-01) -
Significance of C-Reactive Protein in Patients with ST-Elevation Myocardial Infarction Over Non-ST-Elevation Myocardial Infarction
by: Shahzadi Anum, et al.
Published: (2023-01-01)